Concerning liver diseases, NS produced an improvement in liver enzyme parameters (serum aspartate transaminase (AST), alanine transaminase (ALT)), contributing to a significant reduction in markers of inflammation and weight loss in patients with NAFLD. This evidence concerns the gene GPT and liver disorder.